STOCK TITAN
  1. Home
  2. Sec-filings
  3. CLRB
  4. [EFFECT] Cellectar Biosciences INC NEW SEC Filing

[EFFECT] Cellectar Biosciences INC NEW SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 1, 2025 9:00 A.M.
Form: S-1
CIK: 0001279704
Company Name: Cellectar Biosciences, Inc.
File Number: 333-288333

Source: View Original Filing on SEC EDGAR

Stock CLRB logo
Cellectar Biosciences Inc

NASDAQ:CLRB

CLRB Rankings

#6122 Ranked by Market Cap
N/A Ranked by Dividends

CLRB Latest News

Jan 9, 2026
Cellectar Biosciences to Highlight Strategic Initiatives for 2026 at Upcoming Biotech Showcase during 44th Annual JP Morgan Healthcare Conference
Dec 16, 2025
Cellectar Biosciences Announces Strategic Supply Agreement with Ionetix for Actinium-225 and Astatine-211 to Advance Targeted Alpha Therapies
Nov 13, 2025
Cellectar Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Nov 6, 2025
Cellectar Biosciences to Report Third Quarter Financial Results and Host a Conference Call on Thursday, November 13, 2025
Oct 27, 2025
Cellectar Biosciences Receives Rare Pediatric Disease Designation from U.S. Food and Drug Administration for Iopofosine I 131 in Relapsed or Refractory Pediatric High-Grade Glioma

CLRB Latest SEC Filings

Dec 16, 2025
[Form 4] Cellectar Biosciences, Inc. Insider Trading Activity
Nov 21, 2025
[424B3] Cellectar Biosciences, Inc. Prospectus Filed Pursuant to Rule 424(b)(3)
Nov 13, 2025
[8-K] Cellectar Biosciences, Inc. Reports Material Event
Nov 13, 2025
[10-Q] Cellectar Biosciences, Inc. Quarterly Earnings Report
Oct 20, 2025
[S-1] Cellectar Biosciences, Inc. Files IPO Registration Statement

CLRB Stock Data

16.11M
4.05M
5.98%
3.52%
2.01%
Biotechnology
Pharmaceutical Preparations
Link
United States
FLORHAM PARK